Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dermatitis, Atopic

• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
• A Study of TAVO101 in Atopic Dermatitis Patients
• Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis
• A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
• Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis
• A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
• A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
• Dupilumab De-escalation in Pediatric Atopic Dermatitis
• Cardamom and Topical Roseomonas in Atopic Dermatitis
• Evaluate the Safety, Tolerability of BAT6026
• A Phase II Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis
• A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
• Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
• A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
• Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis
• A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
• A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
• Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
• Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis
• This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
• A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
• A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
• A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
• A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD)
• Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
• A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
• Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects With Atopic Dermatitis
• A First-in-Human Study of QY211 Gel in Adult Subjects
• A Study of Hemay005 in Adult With Atopic Dermatitis
• Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
• A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
• A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
• A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)
• Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis
• The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
• Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
• Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
• Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
• A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
• To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
• A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
• To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD
• Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis
• Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
• A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
• Dupilumab Skin Barrier Function and Lipidomics Study in Atopic Dermatitis in China
• CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
• Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children
• A Phase 3, Randomized, Double-Blind Study to Assess the Efficacy of Difamilast Ointment in Mild to Moderate AD
• Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab
• A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
• Dupilumab In Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-seVere Eczema tRial
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
• Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis
• A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
• Bodewell Products for the Treatment of Atopic Dermatitis
• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
• Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
• Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis
• A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
• A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
• Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis
• A Study to Assess Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
• Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis
• A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
• A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)
• A Study of MG-K10 in Subjects With Atopic Dermatitis
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
• Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
• Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis
• A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
• Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
• Study of ATI-1777 in Patients 12 to 65 Years Old With Moderate or Severe Atopic Dermatitis
• A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
• An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
• A Study Evaluating AMG 451 in Moderate To-severe Atopic Dermatitis (ROCKET-IGNITE)
• Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
• A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
• A Safety, Tolerability and Preliminary Efficacy Study of BBI-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
• Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation
• A Study To Learn About The Safety, Efficacy and Tolerability of PF-07038124 Ointment In Participants With Mild-To-Moderate Atopic Dermatitis Or Mild-To-Severe Plaque Psoriasis
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
• A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
• IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
• Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis
• Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
• A Study of Orally Administered IPG7236 in Healthy Adult Participants
• Dupixent and Narrowband UVB for Atopic Dermatitis
• A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermati
• Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study
• Ethnic Differences in Mechanisms of Action of Dupilumab
• A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis
• Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
• Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD
• SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
• Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
• A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
• Tralokinumab Administered With Device A in Adults and Adolescents With Moderate-to-severe Atopic Dermatitis
• Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
• Targeted Investigation of Microbiome Elimination
• A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection
• Phase 2b Study of Efficacy and Safety of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis
• A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine
• Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis
• Study Testing Response Effect of KY1005 Against Moderate to Severe Atopic Dermatitis The STREAM-AD Study
• Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement
• A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
• A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable
• Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
• Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
• Study of Ruxolitinib Cream in Children With Atopic Dermatitis
• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
• Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
• Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
• A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
• Comparison of JW-100 and EUCRISA®
• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
• A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
• The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema
• Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
• A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
• Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
• Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children
• Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis
• EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
• Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
• Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood
• Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
• NMF-CsA-Dupi Trial
• Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
• The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis
• Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
• MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis
• Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
• A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
• Characterizing Skin Microbiome Change in Atopic Dermatitis
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
• A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
• A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
• Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
• A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis
• Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
• Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
• Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
• A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
• The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine
• To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
• Dupilumab in Japanese Patients With Atopic Dermatitis
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis
• A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
• A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis
• Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
• Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
• A First-in-Human Study of CEE321 in Adult Subjects
• Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
• Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis
• A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis
• Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
• Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
• Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
• A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)
• An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis
• Vitamin D in Egyptian Children With Atopic Dermatitis
• Dupilumab Skin Barrier Function Study in Atopic Dermatitis
• A Study Assessing the Efficacy and Safety of CBP-201
• Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.
• Jaktinib Hydrochloride Cream For Atopic Dermatitis
• Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
• Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood
• A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
• A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
• A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
• Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD
• Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
• Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
• Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
• Apremilast 30 mg BID Combined With Dupilumab
• A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
• Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates
• A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis
• Tofacitinib for Immune Skin Conditions in Down Syndrome
• A Study for AR100DP1 in Atopic Dermatitis (AD)
• Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis
• Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
• Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis
• Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis
• Skin bioMARkers for Atopic Eczema Therapy Evaluation
• Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
• A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
• A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
• Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema
• Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
• A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants
• The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover
• A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis
• A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
• A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032
• A Study of LY3471851 in Participants With Eczema
• Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation
• A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
• A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
• Response of Children With Atopic Dermatitis (Eczema) to Eucrisa
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
• The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
• Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
• Dupilumab Impact on Skin Resident Memory T Cells
• Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
• A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
• A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
• A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
• Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064
• Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis
• Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
• Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
• Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
• A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier
• Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis
• A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
• Study in Subjects With Moderate Atopic Dermatitis
• Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
• Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
• Steroid-reducing Effects of Crisaborole
• A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
• Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
• Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
• A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated
• Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
• Study to Evaluate ASN008 Topical Gel (TG)
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
• A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
• Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
• An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
• A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
• A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
• TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
• Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
• Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
• A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
• A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
• Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
• Investigation of Flare and Remission in Subjects With Atopic Dermatitis
• Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
• A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
• Treatment of Nighttime Pruritus in Atopic Dermatitis
• Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis
• The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
• Effect of Different Skin Creams on TEWL
• A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis
• ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis
• Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
• A Trial of Antroquinonol in Patients With Atopic Dermatitis
• Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis
• A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (Measure Up 2)
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
• A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
• Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
• Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients
• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
• A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
• Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis
• Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
• A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
• Effect of Benralizumab in Atopic Dermatitis
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
• Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
• Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
• A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
• Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
• Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
• A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
• A Study Investigating the Efficacy, Safety, and PK Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe AD
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
• A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
• Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis
• A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
• A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
• A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis
• Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
• A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis
• A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisa
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
• Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
• A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
• Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema
• Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
• Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
• Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis
• 8-Week Atopic Dermatitis (AD) Treatment Study
• Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
• A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
• Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
• Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
• Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
• A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
• Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
• A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
• Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients
• Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis
• A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis
• Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
• Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
• A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis
• A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
• Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? The D-Vex Pilot Study
• Eucrisa for Atopic Dermatitis
• Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
• Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis
• A Study in Subjects With Moderate Atopic Dermatitis
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
• Targeted Microbiome Transplant in Atopic Dermatitis
• A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
• Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
• Dose-ranging Study of Nemolizumab in Atopic Dermatitis
• A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis
• Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
• A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
• Evaluating Treatment Resistant Dermatitis TaroIIR
• Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
• Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
• Efficacy and Safety of IDP-124 Lotion
• A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
• Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
• CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis
• Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
• DMT210 Topical Gel in the Treatment of Atopic Dermatitis
• Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
• Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients
• A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis
• Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
• Topical NanoDox® for Atopic Dermatitis
• Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
• Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients
• Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
• Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis
• A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
• Topical Solution for the Treatment of Atopic Dermatitis
• Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
• A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
• A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
• First in Human of Single and Multiple Doses of MOR106
• Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
• Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema
• Topical Steroid Formulation and Wet Wraps
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
• Indigo Naturalis in Treating Atopic Dermatitis Topically
• An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis
• Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
• Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
• Skin Irritation Study of GSK2894512 Cream
• An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids
• Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
• To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
• Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
• Secukinumab for Treatment of Atopic Dermatitis
• A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis
• A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
• Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)
• PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo
• Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?
• Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
• An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
• Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
• Pharmacokinetic Study of Topical GSK2894512 Cream
• A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
• Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
• Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
• A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis
• A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
• A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
• A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
• A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis
• A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
• Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis
• Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
• A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
• Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis
• A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
• Role of Anti-IgE in Severe Childhood Eczema
• Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
• Probiotic Supplementation in Breastfed Newborn Infants
• Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
• Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
• Treatment of Chronic Itch in Atopic Dermatitis (Eczema)
• Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
• 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis
• Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis
• Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
• Oral DS107G in Moderate to Severe Atopic Dermatitis
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
• WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
• WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients
• Study to Determine the Pharmacokinetics of Product 0405
• Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects
• Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects
• Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
• A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis
• Placebo Effect in the Treatment of Atopic Dermatitis
• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis
• Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
• Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
• A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis
• Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization Determination
• Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
• Phase 2 Study of KHK4577
• Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
• Effect of OC000459 on Moderate to Severe Atopic Dermatitis
• Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
• Bleach Bath Treatment of Adults With Atopic Dermatitis
• A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis
• Photocil (Topical) for the Treatment of Atopic Dermatitis
• A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
• Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
• Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival
• Open-label Study of Dupilumab in Patients With Atopic Dermatitis
• A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis
• Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis
• A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paedia
• Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
• Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
• Topical Roflumilast in Adults With Atopic Dermatitis
• Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
• A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis
• An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis
• An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis
• A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
• Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
• Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
• Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
• Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.
• An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
• Emollients in the Management of Atopic Dermatitis
• Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
• Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
• A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)
• A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
• Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients
• Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis
• Investigation of Topical SB705498 on Healthy Volunteers
• Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
• Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
• Effects of Treatments on Atopic Dermatitis
• Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
• Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
• Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
• A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
• Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
• Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment
• A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot
• A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis
• Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
• Efficacy Emollient on Xerosis in Children With Atopic Dermatitis
• A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
• Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
• A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
• Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
• HPA Axis Study in Adults
• HPA Axis Study in Japanese Adults
• Apremilast for Atopic Dermatitis - A Pilot Study in Adults
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
• Pediatric Atopic Dermatitis (AD) Internet Survey
• A Study Assessing GW870086's Potential to Cause Skin Thinning
• CT 327 in the "Atopy Patch Test" Model
• Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
• Vitamin D Deficiency and Atopic Dermatitis
• Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema
• Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
• Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis
• A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)
• Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
• Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis
• Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
• Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)
• Effect of Probiotics in the Atopic Dermatitis
• A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
• A Study of E6005 in Japanese Patients With Atopic Dermatitis
• Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage
• Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
• Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
• Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
• Study of 0417 Ointment in the Treatment of Atopic Dermatitis
• Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
• Pimecrolimus and Epidermal Barrier Function
• Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
• A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults
• A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
• Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema
• Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
• Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
• A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis
• Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
• Study of 0416 Ointment in the Treatment of Atopic Dermatitis
• A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
• the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy
• LEO 29102 Cream in the Treatment of Atopic Dermatitis
• Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
• Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis
• A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
• CT 327 in the Treatment of Atopic Dermatitis
• The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
• Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
• Sinecort Pilot Efficacy Study
• Assessment of the Phototoxic Potential of LEO 29102 Cream
• Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema
• Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis
• A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)
• Study of Apremilast in Atopic or Contact Dermatitis
• Topical Application of AS101 for the Treatment of Atopic Dermatitis
• Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion
• Efficacy and Safety Study of CD2027 Ointment 3 mcg/g Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
• Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)
• The Effectiveness of Montelukast on Atopic Dermatitis in Koreans
• LEO 29102 Single and Multiple Dose Study by Dermal Application
• Management of Pruritus With Xyzal in Atopic Dermatitis
• Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis
• Investigation of Efficacy and Safety of EPOGAM
• Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy
• Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study
• Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus
• Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
• Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
• Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
• Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
• Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients
• VANOS Cream and Skin Barrier Function
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)
• Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children
• Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients
• An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
• Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
• Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
• Effect of Moisturizing Creams on Skin Barrier Function
• Safety Study of AMG 157 in Healthy Subjects and Subjects With Atopic Dermatitis
• A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)
• Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
• A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
• A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
• A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
• Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
• Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
• Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
• Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis
• A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
• Protopic Ointment in Adult Atopic Eczema of the Face
• Protopic Ointment in Children Atopic Eczema
• A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
• Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis
• Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
• A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
• Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis
• Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
• Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis
• Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
• Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis
• Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
• 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
• A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis
• Long-term Safety of Protopic in Atopic Eczema
• Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
• Montelukast as a Controller of Atopic Syndrome
• Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens
• Cutivate Lotion HPA Axis Pediatric Study
• Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
• Distribution of Tacrolimus in Skin, Atopic Dermatitis
• Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis
• Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
• Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old
• Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting
• Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands
• A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis
• Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
• Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
• Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
• Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
• An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
• Prednisolone vs. Ciclosporine in Severe Atopic Eczema
• LEO19123 Cream in the Treatment of Atopic Dermatitis
• The Effects of Probiotics in Atopic Dermatitis
• Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis
• Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis
• Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis
• Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
• Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis
• Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
• Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis
• Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
• Immunopharmacological Effects of Rituximab in Atopic Dermatitis
• Study Of Atopic Dermatitis In Pediatrics
• Short Term Growth in Children With Atopic Dermatitis
• Verification Study of Ciclosporin for Atopic Dermatitis
• Long-term Study of Ciclosporin for Atopic Dermatitis
• Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis
• Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis
• Efalizumab for Moderate to Severe Atopic Dermatitis
• Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis
• Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis
• Elidel-Study: Elidel in Patients With Atopic Dermatitis
• The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
• Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis
• Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
• Efalizumab for Eczema
• Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis
• Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
• Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients
• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis
• Quality of Life Study in Adults With Facial Eczema
• Combination Therapy for Atopic Dermatitis
• Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
• Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)